Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies-Reference-Cited by-同舟云学术

Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies

Published:2024-02-27 Issue:4 Volume:102 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Bridge Francesca¹,Brotherton Julia¹,Stankovich Jim¹,Sanfilippo Paul G.¹,Skibina Olga G.¹,Buzzard Katherine¹,Kalincik Tomas¹^ORCID,Nguyen Ai-Lan¹,Guo Kylie¹,Monif Mastura¹,Wrede C. David¹,Rath Louise¹,Taylor Lisa¹,Butzkueven Helmut¹^ORCID,Jokubaitis Vilija G.¹^ORCID,Van Der Walt Anneke¹^ORCID

Affiliation:

1. From the Department of Neuroscience (F.B., J.S., P.G.S., O.G.S., M.M., H.B., V.G.J., A.V.D.W.), Central Clinical School, Monash University; Department of Neurology (F.B., O.G.S., M.M., L.R., H.B., V.G.J., A.V.D.W.), Alfred Health, Melbourne; Australian Centre for the Prevention of Cervical Cancer (formerly Victorian Cytology Service) (J.B.), Carlton South; Centre for Epidemiology and Biostatistics (J.B.), Melbourne School of Population and Global Health, University of Melbourne; Department of...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000208059

Reference50 articles.

1. Women's Health in Multiple Sclerosis: A Scoping Review

2. The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service

3. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis

4. Blumenthal P, McIntosh N. Cervical Cancer Prevention Guidelines for Low-Resource Settings. Jhpiego; 2005. Accessed February 16, 2022. screening.iarc.fr/doc/CeCaPfullmanual.pdf.

5. The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States